GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Rang in aandelen
#3776
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Aandeelprijs
$25.73
Marktkapitalisatie
$4.36B
Verandering (1 dag)
-5.33%
Verandering (1 jaar)
-17.92%
Land
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Categorie
Healthcare
Koersgeschiedenis voor GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Hoogste slotkoers: $28.33 op 2026-10-01
Laagste slotkoers: $7.46 op 1999-01-01
Laagste slotkoers: $7.46 op 1999-01-01
Koersgeschiedenis van GlaxoSmithKline Pharmaceuticals Limited van 1999 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -0.80% |
| 2025 | 3.53% |
| 2024 | 30.13% |
| 2023 | 28.84% |
| 2022 | -31.26% |
| 2021 | 11.05% |
| 2020 | -8.11% |
| 2019 | 15.01% |
| 2018 | 5.68% |
| 2017 | -5.61% |
| 2016 | -18.58% |
| 2015 | 0.11% |
| 2014 | 11.37% |
| 2013 | 16.93% |
| 2012 | 5.11% |
| 2011 | -25.99% |
| 2010 | 39.42% |
| 2009 | 47.96% |
| 2008 | -8.92% |
| 2007 | -0.02% |
| 2006 | 7.37% |
| 2005 | 41.03% |
| 2004 | 38.71% |
| 2003 | 85.99% |
| 2002 | 3.08% |
| 2001 | -33.62% |
| 2000 | -42.61% |
| 1999 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $1.31K | 61.21% |
US
|
|
| $268.35 | 39.08% |
US
|
|
| $284.58 | 24.44% |
US
|
|
| $147.45 | 68.30% |
US
|
|
| $482.01 | 30.76% |
CH
|
